Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Hemab ApS
APS
Active
CVR 40837590
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
42 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Hemab ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Related companies
Company hierarchy
Hemab Therapeutics Holdings, Inc.
100%
Ebumab Holding ApS
5%
Novo Holdings A/S
15%
SMALLCAP World Fund, Inc.
5%
Ai Den-Mab LLC
10%
GV1 Holding ApS
5%
Deep Track Biotechnology Master Fund, LTD.
5%
Hemab ApS
(this company)
Board network connections
Board members of Hemab ApS also hold positions in
52
other companies.
Person
Role here
Other companies
Kim Stengaard Holmsted
Chairman
19 companies
Many roles
Hans Heugh Wandall
Chairman
7 companies
Many roles
Johan Henrik Faber
Management
5 companies
Søren Erik Bjørn
Board of Directors
5 companies
Thomas Dal Stenfeldt Batchelor
Board of Directors
5 companies
Jørgen Søberg Petersen
Chairman
4 companies
Camilla Petrycer Hansen
Board of Directors
4 companies
Mads Nikolaj Behrndt-Eriksen
Management
3 companies
More on Hemab ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
People & ownership →
Management, board and shareholder breakdown
Hemab Therapeutics Holdings, Inc.
Hemab ApS